Ginkgo Bioworks Holdings (DNA) Income from Continuing Operations (2020 - 2025)
Ginkgo Bioworks Holdings filings provide 6 years of Income from Continuing Operations readings, the most recent being 80751000.0 for Q4 2025.
- On a quarterly basis, Income from Continuing Operations rose 24.91% to 80751000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 312763000.0, a 42.83% increase, with the full-year FY2025 number at 312763000.0, up 42.83% from a year prior.
- Income from Continuing Operations hit 80751000.0 in Q4 2025 for Ginkgo Bioworks Holdings, roughly flat from 80755000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 54464000.0 in Q2 2021 to a low of 1604995000.0 in Q4 2021.
- Median Income from Continuing Operations over the past 5 years was 169494500.0 (2022), compared with a mean of 284783750.0.
- Biggest five-year swings in Income from Continuing Operations: crashed 3503.81% in 2021 and later surged 89.22% in 2022.
- Ginkgo Bioworks Holdings' Income from Continuing Operations stood at 1604995000.0 in 2021, then surged by 89.22% to 173078000.0 in 2022, then decreased by 22.31% to 211694000.0 in 2023, then skyrocketed by 49.2% to 107534000.0 in 2024, then rose by 24.91% to 80751000.0 in 2025.
- The last three reported values for Income from Continuing Operations were 80751000.0 (Q4 2025), 80755000.0 (Q3 2025), and 60300000.0 (Q2 2025) per Business Quant data.